Work

Supplementary Figure 5 from Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects

Year: 2023

Type: supplementary-materials

Abstract: In vivo dabrafenib plus trametinib treatment of mice.

DOI: 10.1158/1541-7786.24474343.v1

Authors: Iñigo Landa, Caitlin E.M. Thornton, Bin Xu, Jacob Haase, Gnana P. Krishnamoorthy, Jingzhu Hao, Jeffrey A. Knauf, Zachary T. Herbert, Paula Martínez, María A. Blasco, Ronald Ghossein, James A. Fagin

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4388112256

Cites:

Cited by:

Related to: